ArticleOrphanet journal of rare diseases2022

Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.

Deborah Elstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.